A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation

This study has been terminated.

Study NCT00563758 Information provided by Hospital Authority, Hong Kong

First Received: August 15, 2007 Last Updated: June 23, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	February 2006
Estimated Primary Completion Date:	No date given